Watch a video intro for this journal

Human Gene Therapy

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editor-in-Chief: Guangping Gao, PhD
European Editor: Hildegard Büning, PhD
Asian Editor: Yu-Quan Wei MD, PhD
Deputy Editors: Mark Kay, MD, PhD, Thierry VandenDriessche, PhD, and Cheng Seng, PhD

ISSN: 1043-0342 | Online ISSN: 1557-7422 | Published Monthly in 12 Double Issues | Current Volume: 34

Impact Factor: 4.793* *2021 Journal Citation Reports™ (Clarivate, 2022)

CiteScore™: 8.2

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene therapy advances.

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts View Submission Instructions Share with a Colleague

Announcements

Follow us on Twitter! @HGTJournal
CALL FOR PAPERS
- Application of Machine Learning and Novel Genome Sequencing Technology in Gene Therapy
  Manuscript Deadline: August 30, 2023
- Ex Vivo Gene Therapy for Genetic Diseases
  Manuscript Deadline: September 30, 2023
- Immune Responses to rAAV Gene Therapy
  Manuscript Deadline: November 1, 2023
Gene and Cell Therapy Connect — a free, comprehensive news source delivered bimonthly to readers. Sign up or View the archive

Featured Content

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.